Literature DB >> 15819408

Protein NO52--a constitutive nucleolar component sharing high sequence homologies to protein NO66.

Jens Eilbracht1, Sandra Kneissel, Astrid Hofmann, Marion S Schmidt-Zachmann.   

Abstract

The nucleolus is the most prominent intranuclear structure of almost all protein-synthesizing cells. It compromises a well-defined functional compartmentalization and a high complexity of molecular constituents. Here, we report on the identification and molecular characterization of a novel constitutive nucleolar component--protein NO52--that is present in diverse species from Xenopus laevis to human. The cDNA-deduced amino acid sequence of protein NO52 defines a polypeptide of a calculated mass of 52.8 kDa and an isoelectric point of 6.7. Inspection of the primary sequence disclosed that the protein contains a JmjC domain and is highly sequence-related to the recently described nucleolar protein NO66. Immunolocalization studies revealed that protein NO52 is highly concentrated in the granular component of nucleoli and this characteristic intranuclear distribution is significantly affected by treatment of cells with (i) RNase A, (ii) actinomycin D and (iii) serum starvation. Interestingly, protein NO52 has been identified as a constituent of free preribosomal particles but is absent from cytoplasmic ribosomes. Analyses of immunocomplexes isolated from cellular extracts with an NO52-specific antibody by MALDI mass spectrometry further confirmed the interaction of protein NO52 with various ribosomal proteins as well as with a distinct set of non-ribosomal nucleolar proteins. The dependence of the nucleolar accumulation of the protein on ongoing rRNA transcription and the cellular metabolic state strongly suggest that protein NO52 is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15819408     DOI: 10.1016/j.ejcb.2004.12.022

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  30 in total

Review 1.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 2.  The small members of the JMJD protein family: Enzymatic jewels or jinxes?

Authors:  Sangphil Oh; Sook Shin; Ralf Janknecht
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-04-26       Impact factor: 10.680

3.  From biological mechanisms to clinical implications: the role of mineral dust-induced gene in lung cancers.

Authors:  Jianjun Zhang; Hongwen Zhao
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

4.  MDIG promotes cisplatin resistance of lung adenocarcinoma by regulating ABC transporter expression via activation of the WNT/β-catenin signaling pathway.

Authors:  Qing Wang; Feng Geng; Haomin Zhou; Yecheng Chen; Juan Du; Xinyu Zhang; Dandan Song; Hongwen Zhao
Journal:  Oncol Lett       Date:  2019-08-22       Impact factor: 2.967

5.  JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation.

Authors:  Yuji Tanaka; Kengo Okamoto; Kwesi Teye; Toshiyuki Umata; Noriyuki Yamagiwa; Yutaka Suto; Yi Zhang; Makoto Tsuneoka
Journal:  EMBO J       Date:  2010-04-08       Impact factor: 11.598

6.  Carcinogenic metalloid arsenic induces expression of mdig oncogene through JNK and STAT3 activation.

Authors:  Jiaying Sun; Miaomiao Yu; Yongju Lu; Chitra Thakur; Bailing Chen; Ping Qiu; Hongwen Zhao; Fei Chen
Journal:  Cancer Lett       Date:  2014-01-14       Impact factor: 8.679

7.  SLR-2 and JMJC-1 regulate an evolutionarily conserved stress-response network.

Authors:  Natalia V Kirienko; David S Fay
Journal:  EMBO J       Date:  2010-01-07       Impact factor: 11.598

8.  MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.

Authors:  M-Y Huang; F Xuan; W Liu; H-J Cui
Journal:  Oncogene       Date:  2016-06-13       Impact factor: 9.867

Review 9.  Mina: a Th2 response regulator meets TGFβ.

Authors:  Meenu R Pillai; Shangli Lian; Mark Bix
Journal:  Curr Opin Immunol       Date:  2014-10-01       Impact factor: 7.486

10.  Increased expression of mdig predicts poorer survival of the breast cancer patients.

Authors:  Chitra Thakur; Yongju Lu; Jiaying Sun; Miaomiao Yu; Bailing Chen; Fei Chen
Journal:  Gene       Date:  2013-12-03       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.